Metabolism of PGI2 by 15-hydroxyprostaglandin-dehydrogenase and delta 13-reductase in different vascular beds of the cat in vivo.
D011452:15-Oxoprostaglandin 13-Reductase; D015121:6-Ketoprostaglandin F1 alpha / Q000031:analogs & derivatives / Q000097:blood; D000804:Angiotensin II / Q000494:pharmacology; D000818:Animals; D001920:Bradykinin / Q000494:pharmacology; D002415:Cats; D003097:Collateral Circulation; D003326:Coronary Circulation; D011464:Epoprostenol / Q000097:blood*; D005260:Female; D006257:Head / Q000098:blood supply; D006614:Hindlimb / Q000098:blood supply; D006911:Hydroxyprostaglandin Dehydrogenases / Q000097:blood*; D008297:Male; D010088:Oxidoreductases / Q000097:blood*; D011453:Prostaglandins / Q000097:blood*; D011461:Prostaglandins F, Synthetic / Q000097:blood; D011652:Pulmonary Circulation
C017239:6,15-diketoprostaglandin F1alpha; D011453:Prostaglandins; D011461:Prostaglandins F, Synthetic; D000804:Angiotensin II; D015121:6-Ketoprostaglandin F1 alpha; C033371:6,15-diketo-13,14-dihydroprostaglandin F1alpha; D011464:Epoprostenol; D010088:Oxidoreductases; D006911:Hydroxyprostaglandin Dehydrogenases; D011452:15-Oxoprostaglandin 13-Reductase; D001920:Bradykinin